secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2024-08-02T23:59:59+00:00
Accession:  0000950170-24-089966
Event type: litigation
Sentiment:  negative
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Biosciences faces $7.3M judgment in LifeSci Capital lawsuit
----------------------------------------------------------------------

- U.S. District Court entered summary judgment against Revelation Biosciences for ~$7.3M in unpaid banking and advisory fees plus interest.
- Judgment adopted Magistrate Judge's December 2023 recommendation; company had contested fee obligation from pre-merger contracts.
- Company states it has sufficient cash to satisfy the judgment and expects no immediate impact on clinical trial programs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000095017024089966/0000950170-24-089966-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000095017024089966/revb-20240801.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-089966

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer